Clinical Trial Update: An Open Label Study to Assess the Efficacy, Safety and Tolerability of COZAAR Plus (Losartan Potassium 50mg/Hydrochlorothiazide 12.5mg) Possibly Titrated up to COZAAR Plus-F (Losartan Potassium 100mg/Hydrochlorothiazide 25mg) in Patients With Essential Hypertension (0954A-325) [Phase 3]

View source ↗

Summary

An open-label Phase 3 trial evaluating COZAAR Plus (losartan potassium/hydrochlorothiazide) and COZAAR Plus-F in essential hypertension was terminated. The upda…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• COZAAR Plus (losartan potassium/hydrochlorothiazide)
• COZAAR Plus-F (losartan potassium/hydrochlorothiazide)

Snippet

Sponsor: Organon and Co | Conditions: Hypertension | Phase 3 | Status: TERMINATED